Home
Invitae

Invitae Market Share Analysis for December 2025

Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion.

Health > Health Conditions and Concerns

Domaininvitae.com

Year Founded2010

Employees1001 - 5000

Annual Revenue$200M - $500M

Invitae

Invitae (including company regionals)

invitae.com

See more website traffic and engagement information

Invitae Revenue up to December 2025 is 200M - 500M

revenue generated by Invitae top domains

Invitae top domains revenue over 3 years

Revenue for Invitae top domains

invitae.com200M - 500M

See more with Sales Intelligence

Total visits to Invitae's top domains

Understand Invitae market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

invitae.com397.9K

See more with Sales Intelligence

Avg. visit duration in Invitae's top domains

Analyze Invitae engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

invitae.com00:03:19

See more with Sales Intelligence

Avg. pageviews on Invitae's top domains

See how Invitae keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

invitae.com6.41

See more with Sales Intelligence

Invitae top competitors by domain

Top similar sites in December 2025, ranked by their affinity

preventiongenetics.comCompany NamePreventionGeneticsEmployees51 - 200HQUnited States, Wisconsin, MarshfieldAnnual revenue$25M - $50MTotal visits29.4KHealth > Health Conditions and Concerns

Top technologies used by Invitae

These are the website technologies, by industry, used by Invitae top domains

Advertising (32)

DoubleClick

Conversion & Analytics (16)

Google Analytics

Social (6)

Instagram

Audio Video Media (5)

Vimeo

More Technologies

15

See all

News & Signals from Invitae

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsInvitae Corp decreases headcount by 1000.During this period, Invitae also laid off more than 1,000 workers.

NewsInvitae Corp launched Pharmacogenomics Panel on May 1st '22.For example, in May 2022, Invitae, a US-based medical laboratory, launched an expanded Pharmacogenomics Panel, offering insights into genetic responses to medications, with a focus on areas like cardiology and oncology.

NewsInvitae Corp launches Unlock Behind the Seizure program, offering accessible and affordable genetic testing for pediatric epilepsy patients under 18.Invitae (OTC: NVTAQ) has launched the Unlock(TM) Behind the Seizure(R) program, offering accessible and affordable genetic testing for pediatric epilepsy patients under 18.